TG Therapeutics Inc (TGTX):企業の財務・戦略的SWOT分析

◆英語タイトル:TG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH59772FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

TG Therapeutics Inc (TGTX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company’s approved product includes Ukoniq for the treatment of relapsed or refractory marginal zone lymphoma and relapsed or refractory follicular lymphoma. Ukoniq is approved in the US. Pipeline products of the company include Ublituximab for the treatment of chronic lymphocytic leukemia (CLL) and multiple sclerosis; Umbralisib for CLL; and Cosibelimab for B-cell cancers among others. The company also offers products and technologies for in-licensing, partnership, acquisition, and investment. The company has operations in the US and Australia. TG Therapeutics is headquartered in New York City, New York, the US.

TG Therapeutics Inc Key Recent Developments

Mar 04,2021: TG Therapeutics to Present Results from the ULTIMATE I & II Phase 3 Trials Evaluating Ublituximab in Multiple Sclerosis at the Upcoming American Academy of Neurology 73rd Annual Meeting
Mar 02,2021: TG Therapeutics provides business update and reports fourth quarter and year-end 2020 financial results
Nov 09,2020: TG Therapeutics provides business update and reports third quarter 2020 financial results
Aug 10,2020: TG Therapeutics provides business update and reports second quarter 2020 financial results
May 14,2020: TG Therapeutics announces data presentations at upcoming medical meetings

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
TG Therapeutics Inc – Key Facts
TG Therapeutics Inc – Key Employees
TG Therapeutics Inc – Key Employee Biographies
TG Therapeutics Inc – Major Products and Services
TG Therapeutics Inc – History
TG Therapeutics Inc – Company Statement
TG Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
TG Therapeutics Inc – Business Description
TG Therapeutics Inc – Corporate Strategy
TG Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
TG Therapeutics Inc – Strengths
TG Therapeutics Inc – Weaknesses
TG Therapeutics Inc – Opportunities
TG Therapeutics Inc – Threats
TG Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
TG Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 04, 2021: TG Therapeutics to Present Results from the ULTIMATE I & II Phase 3 Trials Evaluating Ublituximab in Multiple Sclerosis at the Upcoming American Academy of Neurology 73rd Annual Meeting
Mar 02, 2021: TG Therapeutics provides business update and reports fourth quarter and year-end 2020 financial results
Nov 09, 2020: TG Therapeutics provides business update and reports third quarter 2020 financial results
Aug 10, 2020: TG Therapeutics provides business update and reports second quarter 2020 financial results
May 14, 2020: TG Therapeutics announces data presentations at upcoming medical meetings
May 11, 2020: TG Therapeutics provides business update and reports first quarter 2020 financial results
May 08, 2020: TG Therapeutics strengthens executive team with the addition of Owen A. O’Connor, MD, PhD, as chief scientific officer
Apr 29, 2020: TG Therapeutics Bolsters Board of Directors with the appointment of Sagar Lonial, MD
Mar 03, 2020: TG Therapeutics provides business update and reports fourth quarter and year-end 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
TG Therapeutics Inc, Key Facts
TG Therapeutics Inc, Key Employees
TG Therapeutics Inc, Key Employee Biographies
TG Therapeutics Inc, Major Products and Services
TG Therapeutics Inc, History
TG Therapeutics Inc, Subsidiaries
TG Therapeutics Inc, Key Competitors
TG Therapeutics Inc, Ratios based on current share price
TG Therapeutics Inc, Annual Ratios
TG Therapeutics Inc, Annual Ratios (Cont...1)
TG Therapeutics Inc, Interim Ratios
TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
TG Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
TG Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[TG Therapeutics Inc (TGTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CLP Holdings Limited:発電所・企業SWOT分析
    CLP Holdings Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Strauss Group Ltd.:企業の戦略・SWOT・財務情報
    Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Strauss Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bank Zachodni WBK SA:戦略・SWOT・企業財務分析
    Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report Summary Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MORRE-TEC Industries, Inc.:戦略・SWOT・企業財務分析
    MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary MORRE-TEC Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Capital Lease Aviation Limited:戦略・SWOT・企業財務分析
    Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Mitsubishi Materials Corp:企業の戦略・SWOT・財務情報
    Mitsubishi Materials Corp - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Materials Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Eurofins Scientific SE (ERF):製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, ph …
  • The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • China National Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Petroleum Corp (CNPC) is an integrated energy company. Its businesses cover oil and gas exploration and development, refining and chemicals, marketing and trading, pipeline transmission and stockpiling, technical services, engineering construction, equipment manufacturing, fin …
  • Bellvitge Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center that offers health care development solutions. The center conducts clinical and basic research for developing treatments and techniques to improve health care. It offers its research work in the fields of neuro …
  • Compumedics Ltd (CMP):企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnost …
  • Suncorp Group Ltd:企業の戦略・SWOT・財務情報
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Smiths Group plc:戦略・SWOT・企業財務分析
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kajima Corp (1812):企業の財務・戦略的SWOT分析
    Kajima Corp (1812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Energy XXI Gulf Coast Inc (EXXIQ):企業の財務・戦略的SWOT分析
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Liberty House Group:企業の戦略・SWOT・財務情報
    Liberty House Group - Strategy, SWOT and Corporate Finance Report Summary Liberty House Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ABO Wind AG:電力:M&Aディール及び事業提携情報
    Summary ABO Wind AG (ABO Wind) develops renewable energy projects in Europe. The company carries out the planning and environmental impact assessment, design, development, and operation of wind power projects and biomass power generating facilities. ABO Wind also provides long-term management or mai …
  • W&T Offshore Inc (WTI):企業の財務・戦略的SWOT分析
    W&T Offshore Inc (WTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析
    Summary Clinipace Worldwide Inc (Clinipace) is a contract research company that offers drug and medical devices development services. The company’s services include biostatistics, clinical monitory, chemistry, manufacturing and control, data management, GCP training, global study feasibility, medica …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆